Lessons from the Field

Development of immunohistochemistry services for cancer care in western Kenya: Implications for low- and middle-income countries

Kirtika Patel, R. Matthew Strother, Francis Ndiangui, David Chumba, William Jacobson, Cecelia Dodson, Murray B. Resnic, Randall W. Strate, James W. Smith
African Journal of Laboratory Medicine | Vol 5, No 1 | a187 | DOI: https://doi.org/10.4102/ajlm.v5i1.187 | © 2016 Kirtika Patel, R. Matthew Strother, Francis Ndiangui, David Chumba, William Jacobson, Cecelia Dodson, Murray B. Resnic, Randall W. Strate, James W. Smith | This work is licensed under CC Attribution 4.0
Submitted: 09 May 2014 | Published: 04 May 2016

About the author(s)

Kirtika Patel, Department of Immunology, Moi University, Eldoret, Kenya
R. Matthew Strother, Oncology Department, University of Otago, Christchurch, New Zealand
Francis Ndiangui, Department of Pathology, Moi Teaching and Referral Hospital, Eldoret, Kenya
David Chumba, Department of Pathology, Moi University College of Health Sciences, Eldoret, Kenya
William Jacobson, Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, United States
Cecelia Dodson, Histology Laboratory, Indiana University Health, Indianapolis, Indiana, United States
Murray B. Resnic, Department of Pathology, Brown University, Providence, Rhode Island, United States
Randall W. Strate, Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, United States
James W. Smith, Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, United States

Abstract

Background: Cancer is becoming a major cause of mortality in low- and middle-income countries. Unlike infectious disease, malignancy and other chronic conditions require significant supportive infrastructure for diagnostics, staging and treatment. In addition to morphologic diagnosis, diagnostic pathways in oncology frequently require immunohistochemistry (IHC) for confirmation. We present the experience of a tertiary-care hospital serving rural western Kenya, which developed and validated an IHC laboratory in support of a growing cancer care service.

Objectives, methods and outcomes: Over the past decade, in an academic North-South collaboration, cancer services were developed for the catchment area of Moi Teaching and Referral Hospital in western Kenya. A major hurdle to treatment of cancer in a resource-limited setting has been the lack of adequate diagnostic services. Building upon the foundations of a histology laboratory, strategic investment and training were used to develop IHC services. Key elements of success in this endeavour included: translation of resource-rich practices to are source-limited setting, such as using manual, small-batch IHC instead of disposable- and maintenance-intensive automated machinery, engagement of outside expertise to develop reagent-efficient protocols and supporting all levels of staff to meet the requirements of an external quality assurance programme.

Conclusion: Development of low- and middle-income country models of services, such as the IHC laboratory presented in this paper, is critical for the infrastructure in resource-limited settings to address the growing cancer burden. We provide a low-cost model that effectively develops these necessary services in a challenging laboratory environment.


Keywords

cancer care; immunohistochemistry; LMICs

Metrics

Total abstract views: 7690
Total article views: 11624

 

Crossref Citations

1. Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study
Robert M. Strother, Satish Gopal, Meg Wirth, Amy Chadburn, Ariela Noy, Ethel Cesarman, Jeannette Y. Lee, Scot C. Remick, Naftali Busakhala, Bongani Kaimila, Elson Mberi, Ntokozo Ndlovu, Abrahams Omoding, Susan E. Krown
JCO Global Oncology  issue: 6  first page: 1034  year: 2020  
doi: 10.1200/GO.20.00152

2. An Update of Immunohistochemistry in Hepatocellular Carcinoma
Bingyu Li, Larry Huang, Jialing Huang, Jianhong Li
Diagnostics  vol: 15  issue: 17  first page: 2144  year: 2025  
doi: 10.3390/diagnostics15172144

3. Reporting of diagnostic and laboratory tests by general hospitals as an indication of access to diagnostic laboratory services in Kenya
Felix Bahati, Jacob Mcknight, Fatihiya Swaleh, Rose Malaba, Lilian Karimi, Musa Ramadhan, Peter Kibet Kiptim, Emelda A. Okiro, Mike English, George Vousden
PLOS ONE  vol: 17  issue: 4  first page: e0266667  year: 2022  
doi: 10.1371/journal.pone.0266667

4. Attention-guided and MIL-constrained CycleGAN for high-fidelity virtual p16 and Ki-67 staining
Xinli Lei, Yuefeng Xie, Andi Duan, Yuhang Wu, Linhong Liao, Xi Wang
Frontiers in Medical Technology  vol: 8  year: 2026  
doi: 10.3389/fmedt.2026.1783365

5. Metabolic relevance for N-hydroxy l-arginine reduction in estrogen-negative breast cancer cells
Srinidi Mohan, Seema Patel, Ian Greenstein, Cathy Ng, Kelly Frazier, Giang Nguyen, Lisa Harding, David Barlow
Amino Acids  vol: 50  issue: 11  first page: 1629  year: 2018  
doi: 10.1007/s00726-018-2603-x

6. Tackling the lack of diversity in cancer research
Christian Molina-Aguilar, C. Daniela Robles-Espinoza
Disease Models & Mechanisms  vol: 16  issue: 9  year: 2023  
doi: 10.1242/dmm.050275

7. Novel biomarkers with promising benefits for diagnosis of cervical neoplasia: a systematic review
Calleb George Onyango, Lilian Ogonda, Bernard Guyah, Clement Shiluli, Gregory Ganda, Omenge Elkanah Orang’o, Kirtika Patel
Infectious Agents and Cancer  vol: 15  issue: 1  year: 2020  
doi: 10.1186/s13027-020-00335-2

8. Building capacity for pediatric hematological diseases in Sub-Saharan Africa
Lulu Chirande, Ruth Namazzi, Marilyn Hockenberry, Peter Wasswa, Sarah Kiguli, Tadala Mulemba, Julie M. Gastier-Foster, Magdalena Lyimo, Gladstone Airewele, Joseph Lubega, Nmazuo Ozuah
Blood Advances  vol: 9  issue: 4  first page: 939  year: 2025  
doi: 10.1182/bloodadvances.2024012983

9. Artificial intelligence–assisted FTIR spectroscopy for hormone receptor subtyping in formalin-fixed breast Cancer tissues
Renee George, Cherry Anne Serrano, Jasmine Thea Garong, Kathryn Magsanay, Aleezah Claire Maguigad, Maxene Alexandra De Castro, Andrea Noelle Navarro, Gabrielle Ricci Mandac, Kenaiah Ramos, Maura Isais, Peter Guillen Abanador, Norely Gil, Maria Sarah Lenon, Marie Celestine Trinidad, Angeline Acryl Baldomar, Rock Christian Tomas, Pia Marie Albano
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy  vol: 357  first page: 127781  year: 2026  
doi: 10.1016/j.saa.2026.127781

10. Multi-Field-of-View Deep Learning Model Predicts Nonsmall Cell Lung Cancer Programmed Death-Ligand 1 Status from Whole-Slide Hematoxylin and Eosin Images
Lingdao Sha, Boleslaw L. Osinski, Irvin Y. Ho, Timothy L. Tan, Caleb Willis, Hannah Weiss, Nike Beaubier, Brett M. Mahon, Tim J. Taxter, Stephen S. F Yip
Journal of Pathology Informatics  vol: 10  issue: 1  first page: 24  year: 2019  
doi: 10.4103/jpi.jpi_24_19

11. Addressing Global Disparities in Breast Cancer by Transforming Surgical Pathology in Ethiopia: Early Implementation of Immunohistochemistry
Lesley Taylor, Rebecca A. Nelson, Teketel Tadesse Geremew, Meron Gebrekirstos Teklehaimanot, Daniel Schmolze, Alemwosen Teklhaymanot Alem
JCO Global Oncology  issue: 11  year: 2025  
doi: 10.1200/GO-25-00178